Celgene Corporation v. Hetero Labs Limited
| CELGENE CORPORATION |
| HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-V, HETERO DRUGS LIMITED, HETERO USA, INC., AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC., AUROLIFE PHARMA LLC, EUGIA PHARMA SPECIALTIES LIMITED, APOTEX INC., APOTEX CORP., BRECKENRIDGE PHARMACEUTICAL, INC., MYLAN PHARMACEUTICALS, INC., MYLAN INC. and MYLAN N.V. |
| 21-2335 |
| September 21, 2021 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 15, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 Official caption revised to reflect non-appearance of Appellees Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Breckenridge Pharmaceutical, Inc., Eugia Pharma Specialties Limited, Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc. (see attached). Service as of this date by the Clerk of Court. [806045] [JCW] [Entered: 10/15/2021 01:58 PM] |
| Filing 11 Corrected Docketing Statement for the Appellant Celgene Corporation. Service: 10/12/2021 by email. [804995] [21-2335] [Francis Cerrito] [Entered: 10/12/2021 02:36 PM] |
| Filing 10 Notice to Appellees Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Aurolife Pharma LLC, Breckenridge Pharmaceutical, Inc., Eugia Pharma Specialties Limited, Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA, Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [804946] [JCW] [Entered: 10/12/2021 01:24 PM] |
| Filing 9 Docketing Statement for the Appellees Mylan Inc., Mylan N.V. and Mylan Pharmaceuticals, Inc.. Service: 10/06/2021 by email. [803999] [21-2335] [Tung Kong] [Entered: 10/06/2021 02:10 PM] |
| Filing 8 Official caption revised to add Mylan Pharmaceuticals, Inc., Mylan Inc. and Mylan N.V. to the case. (see attached). Service as of this date by the Clerk of Court. [803911] [JCW] [Entered: 10/06/2021 11:18 AM] |
| Filing 7 Certificate of Interest for Mylan Pharmaceuticals, Inc.; Mylan Inc.; Mylan N.V.. Service: 10/05/2021 by email. [803846] [21-2335] [Tung Kong] [Entered: 10/05/2021 08:13 PM] |
| Filing 6 Entry of appearance for Tung-On Kong; Elham F. Steiner; Kristina M. Hanson; Steffen N. Johnson as counsel for Mylan Pharmaceuticals, Inc.; Mylan Inc.; Mylan N.V.. Service: 10/05/2021 by email. [803845] [21-2335] [Tung Kong] [Entered: 10/05/2021 08:11 PM] |
| Filing 5 NOTICE OF NON-COMPLIANCE: The submission of Appellant Celgene Corporation, Docketing Statement [ # 3 ], is not in compliance with the rules of this court (see attached). Compliant document due on 10/13/2021. Service as of this date by the Clerk of Court. [803713] [JCW] [Entered: 10/05/2021 02:07 PM] |
| Filing 4 Certificate of Interest for Appellant Celgene Corporation. Service: 10/05/2021 by email. [803683] [21-2335] [Francis Cerrito] [Entered: 10/05/2021 01:28 PM] |
| Filing 3 Docketing Statement for the Appellant Celgene Corporation. Service: 10/05/2021 by email. [803682] [21-2335] This document is non-compliant. See Doc No.[ # 5 ] [Francis Cerrito] [Entered: 10/05/2021 01:26 PM] |
| Filing 2 Entry of appearance for F. Dominic Cerrito; Eric C. Stops; Frank C. Calvosa; Ellyde R. Thompson; Jennifer L. Swize; Matthew J. Hertko as counsel for Appellant Celgene Corporation. Service: 10/05/2021 by email. [803681] [21-2335] [Francis Cerrito] [Entered: 10/05/2021 01:25 PM] |
| Filing 1 Appeal docketed. Received: 09/20/2021. [800909] Entry of Appearance is due on 10/05/2021. Certificate of Interest is due on 10/05/2021. Docketing Statement is due on 10/05/2021. Appellant's brief is due on 11/22/2021. [JCW] [Entered: 09/21/2021 04:46 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
